SCHEMBL770900

SCHEMBL770900

C=CC(=O)OCCOCCOCCN(C)C

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.70
TSHR P16473 6/20 0.70
TP53 P04637 3/20 0.70
HIF1A Q16665 3/20 0.70
HSD17B10 Q99714 1/20 0.70
THRB P10828 2/20 0.53
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
HPGD P15428 1/20 0.48
CYP3A4 P08684 2/20 0.48
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
CHRM5 P08912 1/20 0.42
CHRM1 P11229 1/20 0.42
CHRNB2 P17787 1/20 0.42
CHRM3 P20309 1/20 0.42
CHRNA4 P43681 1/20 0.42
KDM4E B2RXH2 6/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2794243 1.00 ALDH1A1 (0.70) ALDH1A1TSHRTP53HIF1AHSD17B10
SCHEMBL30508441 0.89 TSHR (0.55) ALDH1A1TSHRTP53HIF1AHSD17B10
SCHEMBL6657526 0.89 TSHR (0.55) ALDH1A1TSHRTP53HIF1AHSD17B10
SCHEMBL26944275 0.89 TSHR (0.70) ALDH1A1TSHRTP53HIF1AHSD17B10
SCHEMBL15115 0.88 TSHR (0.56) ALDH1A1TSHRTP53HIF1AHSD17B10
Hydrochloric Acid SCHEMBL130714 0.86 TSHR (0.54) ALDH1A1TSHRTP53HIF1AHSD17B10
SCHEMBL28612529 0.86 TSHR (0.54) ALDH1A1TSHRTP53HIF1AHSD17B10
Iodide SCHEMBL1254059 0.86 TSHR (0.54) ALDH1A1TSHRTP53HIF1AHSD17B10
Ethylene SCHEMBL8397415 0.86 TSHR (0.54) ALDH1A1TSHRTP53HIF1AHSD17B10
Fluoride SCHEMBL1255037 0.86 TSHR (0.54) ALDH1A1TSHRTP53HIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8753615-B2 Ethylene copolymer with PEG, cationic and anionic units, cosmetic composition including same and treatment method L'OREAL (FR) 2014-06-17 US disclosed
US-8753615-B2 Ethylene copolymer with PEG, cationic and anionic units, cosmetic composition including same and treatment method L'OREAL (FR) 2014-06-17 US disclosed
US-20120070399-A1 ETHYLENE COPOLYMER WITH PEG, CATIONIC AND ANIONIC UNITS, COSMETIC COMPOSITION INCLUDING SAME AND TREATMENT METHOD L'OREAL (FR) 2012-03-22 US disclosed
US-20120070399-A1 ETHYLENE COPOLYMER WITH PEG, CATIONIC AND ANIONIC UNITS, COSMETIC COMPOSITION INCLUDING SAME AND TREATMENT METHOD L'OREAL (FR) 2012-03-22 US disclosed
WO-2010116063-A1 ETHYLENE COPOLYMER WITH PEG, CATIONIC AND ANIONIC UNITS, COSMETIC COMPOSITION INCLUDING SAME AND TREATMENT METHOD L'OREAL (FR) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070399-A1 ETHYLENE COPOLYMER WITH PEG, CATIONIC AND ANIONIC UNITS, COSMETIC COMPOSITION INCLUDING SAME AND TREATMENT METHOD EGFR, ERCC1, ERCC5 ALDH1A1 1329/4885TSHR 2468/4885TP53 642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.